Gabriela A.: New FDA Approval Advances the Future of Dried Plasma
Gabriela A., Project Coordinator at UT Health San Antonio, shared a post on LinkedIn:
”The FDA’s recent approval of ‘Ezplaz’, the first-ever-dried plasma product licensed in the United States, marks a major advancement in trauma care, particularly for military, emergency response, and other austere environments where traditional blood products are difficult to store and transport.
This milestone highlights the growing momentum behind blood preservation research, including TRC4-supported work at UTAustin, where investigators are exploring innovative thin-film freeze-drying approaches that could help shape the future of blood product storage, transport, and use in austere environments.
It’s exciting to see innovations once considered aspirational become reality, while groundbreaking research across The University of Texas System continues to transform bold ideas into real-world solutions.”
Stay uodated withย Hemostasis Today.
-
Oct 1, 2026, 11:17Elastic Stockings for VTE Prevention – RPTH Journal
-
Oct 1, 2026, 10:34Thomas Vallim: New Protocol Improves Measurement of AAV-CRISPR Gene Editing
-
Oct 1, 2026, 10:05Guillaume Baudry: Landmark Clinical Trials Shaping Modern Heart Failure Therapy
-
Oct 1, 2026, 09:48Lesley Van Wyk: JAMA – A Newly Identified Blood Group System
-
Oct 1, 2026, 09:19Pauline Schuitema: Lipemic Index May Help Identify Severe Lipid Disorders
-
Oct 1, 2026, 07:52Marc Carrier: TRIM-Line Trial Evaluates VTE Prevention in Cancer
-
Oct 1, 2026, 07:29Ariela Marshall: New Guidelines Provide Updated Recommendations for Iron Deficiency Diagnosis
-
Sep 30, 2026, 22:28Recent Mechanical Risk Factors and Young-Onset Cryptogenic Ischemic Stroke – American Heart Association International
-
Sep 30, 2026, 22:22Expert Consensus on Inferior Vena Cava Thrombosis – Thrombosis and Haemostasis Journal